Detalhe da pesquisa
1.
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J Neurooncol
; 144(3): 501-509, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325144
2.
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.
Oncologist
; 22(5): 570-575, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28360216
3.
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Lancet Oncol
; 17(11): 1533-1542, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686943
4.
Autoantibodies Against the Purkinje Cell Protein RGS8 in Paraneoplastic Cerebellar Syndrome.
Neurol Neuroimmunol Neuroinflamm
; 8(3)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782191
5.
Immunohistochemical comparative analysis of GFAP, MAP - 2, NOGO - A, OLIG - 2 and WT - 1 expression in WHO 2016 classified neuroepithelial tumours and their prognostic value.
Pathol Res Pract
; 214(1): 15-24, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29258767